The SCN 997 update for MassLynx represents a powerful upgrade for users of the Waters’ Mass Spectrometry software, boasting 12 enhancements, 24 bug fixes, and 7 performance and 11 usability improvements.
Waters Arc Premier Solution is optimized with MaxPeak HPS Technology and developed for use with 2.5 µm MaxPeak HPS Columns to deliver improvements in separation and detection of metal-sensitive analytes.
Are you ready for the next generation of high resolution mass spectrometry (HRMS) platforms? The state-of-the-art hybrid quadrupole Time-of-Flight (Q-ToF) SELECT SERIES MRT is a groundbreaking addition to Waters’ SELECT SERIES family. Incorporating Multi… Read more >
Waters’ latest product launch will supercharge the role of mass spectrometry research in the fight against SARS-CoV-2. Scientists can now directly quantify specific viral NCAP peptides in a highly reproducible manner with the Waters SARS-CoV-2 LC-MS Kit (RUO), allowing breakthrough research of the SARS-CoV-2 virus.
As chromatographers seek maximum separation performance on their liquid chromatography (LC) systems, a key factor is the use of LC columns with an optimally packed column bed density. Solid-core columns manufactured with strict quality control… Read more >
Driven by the global COVID-19 pandemic, consumers increasingly seek food and beverages that support immunity and health. As a result, the global functional beverages market is expected to grow to $158 billion in 2023. Waters HPLC and UPLC solutions enable reliable, accurate, and efficient testing methods to ensure that finished beverage products meet manufacturers’ specifications and nutritional label claims.
Critical SARS-CoV-2 PCR based diagnostics have not been immune to the supply chain disruptions so common during the COVID-19 pandemic. While the biggest disruption for PCR based testing was RNA extraction kits, enzymes and PCR primers have been affected as well. At Waters, we’ve kept a close eye on the role that high-quality preparative HPLC columns play in the PCR primer and probe supply chain. As we forge ahead through this pandemic and beyond, we will continue to help ensure adequate quality and supply of PCR primers and probes for diagnostics and routine use.
The worldwide coronavirus pandemic has changed the way that scientists and companies work. Learn how the Waters COVID-19 Innovation Response Team enabled the critical collaboration and pooling of expertise that enabled fast and safe vaccine development.
The development of biotherapeutics continues to accelerate with their potential to revolutionize disease treatment in areas not adequately addressed by small molecule therapeutics. However, the complexity of these macromolecules and the range of potential modification… Read more >
To ensure compliance success in a changing regulatory landscape, laboratories must continually adapt. Learn how the compliant-ready Waters BioAccord LC-MS platform helps biopharma address the additional compliance challenges posed by the field’s complex analytical instruments.